For the first time in more than 20 years, U.S. regulators are considering the reintroduction of bovine (cow-derived) heparin into the U.S., helping to address concerns about potential shortages and adulteration issues associated with this widely-used drug.
There’s something about an anniversary that inspires me to look to the future as well as appreciate the past, especially at the start of a new year. As we mark the anniversary of the 10th year of USP-China, the future and the past offer a great deal to appreciate.
USP-China is working collaboratively with China’s local governments and other key stakeholders to advance the quality of medicines and food in China and globally.
Tuberculosis (TB) is one of the world’s most prevalent diseases – it kills three people every minute. Although progress has been made in expanding access to treatment, the rate of multi-drug resistant TB cases has nearly doubled between 2011 and 2012. One factor driving drug resistance is poor quality drugs. Several global health organizations have partnered together to find a solution to ensure that safe and effective medicines are used in their treatment programs.